Patent · US Active

Vaccine and methods to reduce campylobacter infection

US8961990B2 · kind B2 · utility

16Cited by
24References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2011
Grant dateFeb 24, 2015
Priority date
Expiry dateJun 9, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vaccine vectors and methods for enhancing resistance to Campylobacter infection or for enhancing the immune response to Campylobacter are provided herein. The vaccine vectors include a first polynucleotide which encodes an antigenic polypeptide selected from SEQ ID NO 7-9 or a fragment thereof. The vector may also include an immunostimulatory polypeptide. The methods include administering the vaccine vectors to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.